The health care lawyers at McGuireWoods use The Healthcare Investor to share insights on issues and trends that impact investments in healthcare & life sciences businesses. This blog is authored by Amber Walsh and Kristian Werling.
- Practice Area
- Administrative Law
- Admiralty & Maritime Law
- Advertising Law
- Alternative Dispute Resolution
- AmLaw 200 Blogs
- Antitrust Law
- Civil Rights & Privacy Law
- Consumer Law
- Corporate & Commercial Litigation
- Criminal Law
- Divorce & Family Law
- Education Law
- Election Law & Political Commentary
- Electronic Discovery
- Employment & Labor Law
- Environmental Law
- General Counsel Blogs
- Immigration Law
- Insurance Law
- Intellectual Property Law
- International Law
- Judiciary Law
- Media, Entertainment & Sports Law
- Law Firm Management & Legal Marketing
- Personal Injury & Medical Law
- Probate & Estate Planning
- Real Estate & Construction Law
- Tax & Financial Law
- Whistleblower Law
- Workers' Compensation
- Law School
Information and the means of communicating that data in a cost-effective, secure, user-friendly and legally compliant manner is critical in any industry. Targeted healthcare-related IT, information technology specifically designated to improve patient care and advance quality and efficiency...
When looking for the latest investment opportunities in the healthcare arena, one major priority for many investors is information technology, IT. A National Venture Capital Association recent survey showed that 61% of venture capitalists feel that investments in health IT will increase this year....
Perhaps despite not having the cache of ‘guaranteed-weight-loss’, ‘quit smoking now’ or even a cure-all for cancer, pharmaceuticals for the treatment of rare diseases can be an attractive investment strategy. Amicus Therapeutics is the developer of small molecule, orally...
As we round out our series on private equity investing in dialysis, we note an emergence in overseas dialysis investing by U.S. investors. Our blog typically focuses on U.S. investing but can’t help but note the interest in overseas activity. In particular, dialysis centers...
Part II of our series on private equity investing in dialysis discusses other dialysis companies backed by private equity and highlights some key considerations for investors and companies. Funded in 2000, U.S. Renal Care (USRC), is another dialysis company (generally considered an...
Private equity investors have been active in the dialysis sector for decades. In Part I of this series on dialysis investments, we describe the recent emergence of three companies with private equity backing. First, in 2010 Bain Capital Ventures and KRG Capital invested in Liberty...
Put aside your Sony flat-screen TVs and Blu-Ray players and make way for ---flow cytometry. Why is Sony Corporation, a proven global manufacturer in the field of audio, video game, communications, key device and information technology, venturing in the turbulent, albeit often lucrative waters of...
McGuireWoods to Host 9th Annual Healthcare & Life Sciences Private Equity & Finance Conference February 22-23
We have recently published the final agenda for our upcoming 9th Annual Healthcare & Life Sciences Private Equity & Finance Conference to be held on February 22-23 at The Ritz-Carlton in Chicago. We are again co-hosting with McGladrey and are pleased to have another outstanding group...
Pitchbook has reported on a decade of private equity investments in a four-part series focusing on investments, fundraising, exits and fund returns. The highlights are illuminating of the period from 2001 through 2010, with the unsurprising peak in 2007 and drop...
We have descrived in prior posts the opportunities available through Accountable Care Organizations. ACOs are intended to provide physicians and medical centers financial incentives to continue offering high-quality medical services to their Medicare patients while keeping costs at...